TO OPTIMIZATION OF THE TREATMENT OF CHRONIC URETHRITIS CAUSED BY SEXUALLY TRANSMITTED INFECTIONS

O. A. Singur; A. D. Yutskovsky; L. G. Singur

doi:10.17816/rmj38000

Russian Medicine ›› 2012, Vol. 18 ›› Issue (3) : 29 -32. DOI: 10.17816/rmj38000

Articles

research-article

TO OPTIMIZATION OF THE TREATMENT OF CHRONIC URETHRITIS CAUSED BY SEXUALLY TRANSMITTED INFECTIONS

Author information +

History +

PDF

Abstract

The epidemiological features of individual pathogens of sexually transmitted infections, which cause urogenital tract inflammatory diseases, their susceptibility to antibacterial drugs, and β-lactamase activity were studied. Gonorrhea was ascertained to run as an associated infection in 68% of cases with the predominance of microbial associations with Staphylococcus aureus (52%) in the epidemiological structure. There was a substantial rise in the proportion of Neisseria gonorrheae and S. aureus strains producing β-lactamase (95.8 and 93%, respectively). There was a high antibiotic resistance of S. aureus and Escherichia coli strains in association with gonococcus, an increase in the resistance of Ureaplasma urealiticum, Mycoplasma hominis, and M genitalium strains isolated in mixed infections (by 1.25-5.8 times), and a decrease in gonococcal antibiotic susceptibility (by 4 times) in mixed infections. The findings substantiate it necessary to examine for concurrent microflora simultaneously with the identification of a pathogen and the regular monitoring of antibiotic susceptibility in all the isolated pathogens of mono and mixed infections.

Keywords

Neisseria gonorrheae / Staphylococcus aureus / Neisseria gonorrheae / Staphylococcus aureus / mixed infection / antibiotic resistance

Cite this article

Download citation ▾

O. A. Singur, A. D. Yutskovsky, L. G. Singur. TO OPTIMIZATION OF THE TREATMENT OF CHRONIC URETHRITIS CAUSED BY SEXUALLY TRANSMITTED INFECTIONS. Russian Medicine, 2012, 18(3): 29-32 DOI:10.17816/rmj38000

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Белькова Ю. А., Дехнич А. В., Козлов Р. С. // Вестн. дерматол. — 2011. — № 1. — С. 41—53.

[2]	Герасимова Н. М., Евстигнеева Н. П., Кузнецова Ю. Н. // Дальневосточный вестн. дерматовенерол., дерматокосметол. и сексопатол. — 2009. — № 2 (5). — С. 43—45.

[3]	Колиева Г. Л. Клинико-микробиологический и фармакологический анализ эффективности лечения неосложненной гонореи: Автореф. дис.. канд. мед. наук. — М., 2004.

[4]	Кубанова А. А. // Вестн. дерматол. — 2008. — № 5. — С. 8—18.

[5]	Лесная И. Н., Соломка В. С., Фриго Н. В. и др. // Вестн. дерматол. — 2010. — № 5. — С. 65—73.

[6]	Мавров И. И. Половые болезни. — М.: АСТ-Пресс-книга, 2002.

[7]	Молочков В. А., Гущин А. Е. Гонорея и ассоциированные инфекции. — М., 2006.

[8]	МУК 4.2.1890—04. Определение чувствительности микроорганизмов к антибактериальным препаратам. — М., 2004.

[9]	Сингур Л. Г. Микрофлора вагины и местный иммунитет при гонорее у женщин разных изогеногрупп: Дис.. канд. мед. наук. — Владивосток, 1986.

[10]	Юцковский А. Д., Юцковская Я. А. // Вестн. последипломного мед. образования. — 2009. — № 1. — С. 6—7.

[11]	Lee K., Chong Y., Erdenechemeg L. et al. Incidence, epidemiology and evolution of reduced susceptibility to ciprofloxacin in Neisseria gonorrhoeae in Korea. Clin. Microbiol. Infect. 1998; 4: 11: — P. 627—633.